ANTI-PD-L1/IL-15 KD033 ACTIVATED MACROPHAGES AND INDUCED ANTI-TUMOR IMMUNITY IN THE TUMOR-MICROENVIRONMENT

被引：0

作者：

Martomo, Stella ^{[1
]}

Wang, George ^{[1
]}

Polonskaya, Zhanna ^{[1
]}

Luna, Xenia ^{[1
]}

Lu, Dan ^{[1
]}

Patel, Jeegar ^{[1
]}

机构：

[1] Kadmon Corp, New York, NY USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.652

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

652

引用

页码：A681 / A681

页数：1

共 50 条

[31] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1 [J].

Jiming Chen ;

Jie Yang ;

Wenhui Wang ;

Danfeng Guo ;

Chengyan Zhang ;

Shibo Wang ;

Xinliang Lu ;

Xiaofang Huang ;

Pingli Wang ;

Gensheng Zhang ;

Jing Zhang ;

Jianli Wang ;

Zhijian Cai .

Cellular & Molecular Immunology, 2022, 19 :1290-1301

[32] Engineered Mycobacterium smegmatis expressing anti-PD-L1/IL-15 immunocytokine induces and activates specific antitumor immunity [J].

Mei, Yi ;

Zhu, Junmeng ;

Shao, Jie ;

Li, Lin ;

Liu, Fangcen ;

Sha, Xiaoxuan ;

Yang, Yang ;

Shen, Jie ;

Li, Rutian ;

Liu, Baorui .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (05)

[33] A targeted IL-15 fusion protein with potent anti-tumor activity [J].

Chen, Siqi ;

Huang, Qiang ;

Liu, Jiayu ;

Xing, Jieyu ;

Zhang, Ning ;

Liu, Yawei ;

Wang, Zhong ;

Li, Qing .

CANCER BIOLOGY & THERAPY, 2015, 16 (09) :1415-1421

[34] Inhibition of A2AR induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical and clinical studies [J].

Willingham, Stephen ;

Hotson, Andrew ;

Ho, Po ;

Choy, Carmen ;

Walter, Kim ;

Yusko, Erik ;

Benzeno, Sharon ;

Laport, Ginna ;

Miller, Richard ;

McCaffery, Ian .

CANCER RESEARCH, 2017, 77

[35] Anti-tumor and immune effects of olaparib plus /- anti-PD-L1 in preclinical BRCA1mut tumor models [J].

Staniszewska, Anna ;

Armenia, Joshua ;

King, Matthew ;

Michaloglou, Chrysiis ;

Singh, Maneesh ;

San Martin, Maryann ;

Wilson, Zena ;

Proia, Theresa ;

Delpuech, Oona ;

O'Connor, Mark ;

Leo, Elisabetta ;

Valge-Archer, Viia .

CANCER RESEARCH, 2020, 80 (16)

[36] Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma [J].

Hsu, Fei-Ting ;

Liu, Yu-Chang ;

Tsai, Chang-Liang ;

Yueh, Po-Fu ;

Chang, Chih-Hsien ;

Lan, Keng-Li .

CANCERS, 2021, 13 (08)

[37] Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy [J].

Nan, Yanyang ;

Bai, Yu ;

Hu, Xiaozhi ;

Zhou, Kaicheng ;

Wu, Tao ;

Zhu, An ;

Li, Mengyang ;

Dou, Zihan ;

Cao, Zhonglian ;

Zhang, Xumeng ;

Xu, Shuwen ;

Zhang, Yuanzhen ;

Lin, Jun ;

Zeng, Xian ;

Fan, Jiajun ;

Zhang, Xuyao ;

Wang, Xuebin ;

Ju, Dianwen .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (09)

[38] Cimetidine Attenuates Therapeutic Effect of Anti-PD-1 and Anti-PD-L1 and Modulates Tumor Microenvironment in Colon Cancer [J].

Kuo, Feng-Chi ;

Lai, Jerry Cheng-Yen ;

Shieh, Hui-Ru ;

Liou, Wan-Zu ;

Bair, Ming-Jong ;

Chen, Yu-Jen .

BIOMEDICINES, 2024, 12 (03)

[39] Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo [J].

Maohua Li ;

Rongqing Zhao ;

Jianxin Chen ;

Wenzhi Tian ;

Chenxi Xia ;

Xudong Liu ;

Yingzi Li ;

Song Li ;

Hunter Sun ;

Tong Shen ;

Wenlin Ren ;

Le Sun .

Scientific Reports, 12

[40] Peritumoral IL-15 Promotes Regional NK Activation and DC Licensing to Augment Radiation-Induced Anti-tumor Immunity [J].

Pilones, K. A. ;

Daviaud, C. ;

Garcia-Martinez, H. ;

Formenti, S. C. ;

Demaria, S. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02) :S162-S162

← 1 2 3 4 5 →